HOME >> BIOLOGY >> NEWS
Next phase reached in definition of Mars Sample Return mission

ESA has taken a further step in preparing for participation in Mars Sample Return (MSR), the landmark mission to return samples from the Red Planet, with the announcement of the next phase of industrial activity.

The Phase A2 activity will address many critical issues and identify key areas in which Europe can participate in this flagship of the Aurora Programme.

The search for evidence of life outside the Earth is one of the fundamental goals of space exploration, and has been one of the driving forces behind the efforts to explore the planet Mars. This investigation, key to unlocking the 'big' question regarding life in the universe, is increasing in pace and is already beginning to provide answers. This is also one of the leading scientific threads of ESA's Aurora Space Exploration Programme that was approved at the ESA Council meeting at Ministerial level held in Berlin last December.

Currently four orbiting explorers are scanning the surface of Mars in ever more detail, including Europe's own Mars Express, while on the Red Planet itself two NASA rovers are due to be joined in 2013 by ESA's ExoMars rover. The ExoMars mission will take Mars exploration and the search for life to a new level, with an advanced set of life detection instruments as well as the capability to drill into the Martian surface to search for signs of life, a first for Mars. These missions, while providing a wealth of data, are however somewhat limited in that they must take the laboratory to Mars, facing restrictions on power, mass and having to carry out scientific operations in a very harsh environment. The obvious question then arises; why not bring Mars to the laboratory? Hence, the Mars Sample Return (MSR) mission.

The MSR mission has been recognised by European and International scientists as one of the next major milestones in the exploration of the Red Planet, and would represent a quantum leap in the study of possible life there with scientists
'"/>

Contact: Piero Messina
piero.messina@esa.int
33-015-369-7410
European Space Agency
7-Apr-2006


Page: 1 2 3

Related biology news :

1. CTRC enrolls first patients in novel phase II study for sarcoma -- living virus destroys cancer cell
2. Minister Lunn announces $39.6M for next phase of mountain pine beetle response
3. BDSI announces positive phase III clinical trial results
4. OneWorld Health selects Odyssey Research for phase 4 study in India
5. NIH announces phase III clinical trial of creatine for Parkinsons disease
6. Orexigen reports positive phase II results for Excalia Combination-Therapy to treat obesity
7. UK Biobank gets unanimous backing from international experts after piloting phase
8. NYU scientists begin second phase of project to better understand disease
9. New phase for Global Biodiversity Information Facility
10. Rangeland repair enters phase 2
11. Five Spanish hospitals in international phase III trial with H5N1 influenza pandemic vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/25/2019)... ... March 25, 2019 , ... Researchers have found multiple applications ... it came into use by the scientific community. Keck Graduate Institute (KGI) Assistant ... to combine the power of CRISPR’s nucleic acid targeting with the ultra sensitivity ...
(Date:3/23/2019)... (PRWEB) , ... March 22, 2019 , ... ... Kit for Next Generation Sequencing (NGS) sample preparation. RhinoSeq employs a proprietary kit ... market. The five-tube kit is comprised of preformatted master mixes for a simple, ...
(Date:3/18/2019)... ... March 18, 2019 , ... ... the microbiome industry and the third highest quality portfolio following Seres Health and ... Manuel Fankhauser, Christian Moser, and Theodor Myfleler. uBiome executives Dr. Jessica Richman, PhD, ...
Breaking Biology News(10 mins):
(Date:4/16/2019)... ... April 16, 2019 , ... On April 24th, ... the U.S. Army Center for Environmental Health Research (USACEHR), with an award for ... Blue Sources, a veteran-owned company located at the Frederick Innovative Technology Center, Inc. ...
(Date:4/10/2019)... ... 2019 , ... After more than three months of renovation, Lajollacooks4u is set ... updated appliances and modern lighting and fixtures, and will provide additional workspace for the ... tremendous growth in the demand for our team-building events and cooking classes over the ...
(Date:4/8/2019)... ... , ... US Capital Global Securities , an affiliate of US Capital ... privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has a pipeline of drugs ... dysfunction disorder and is ready to begin phase 2b trials. In phase 2a trials, ...
(Date:3/27/2019)... ... ... A leader in the field of Regenerative Veterinary Medicine, VetStem Biopharma has ... Canada since 2004. The primary indications for VetStem Regenerative Cell Therapy are ... and horse. Recently, VetStem teamed up with the world-renowned San Diego Zoo to ...
Breaking Biology Technology:
Cached News: